Expression patterns and prognostic significances of RRM1 and ERCC1 in pancreatic carcinoma and cholangiocarcinoma

Background: Aggressive pancreatobiliary tumors often require oxaliplatin-based therapies, instead of standard gemcitabine-based therapy and biomarker studies at diagnosis to decide the appropriate therapeutic regimen. The ribonucleotide Reductase catalytic subunit M1 (RRM1) and excision repair cross...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Khushbu Khetan, Ranjit K Sahoo, Vandana Baloda, Shalimar, Sreenivas Vishnubhatla, Anoop Saraya, Nihar Ranjan Dash, Atul Sharma, Siddhartha DattaGupta, Prasenjit Das
Formato: article
Lenguaje:EN
Publicado: Wolters Kluwer Medknow Publications 2021
Materias:
Acceso en línea:https://doaj.org/article/0308f19bce6a47979b52fb9fb0ccd539
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:0308f19bce6a47979b52fb9fb0ccd539
record_format dspace
spelling oai:doaj.org-article:0308f19bce6a47979b52fb9fb0ccd5392021-12-02T17:28:22ZExpression patterns and prognostic significances of RRM1 and ERCC1 in pancreatic carcinoma and cholangiocarcinoma0377-492910.4103/IJPM.IJPM_537_19https://doaj.org/article/0308f19bce6a47979b52fb9fb0ccd5392021-01-01T00:00:00Zhttp://www.ijpmonline.org/article.asp?issn=0377-4929;year=2021;volume=64;issue=5;spage=160;epage=165;aulast=Khetanhttps://doaj.org/toc/0377-4929Background: Aggressive pancreatobiliary tumors often require oxaliplatin-based therapies, instead of standard gemcitabine-based therapy and biomarker studies at diagnosis to decide the appropriate therapeutic regimen. The ribonucleotide Reductase catalytic subunit M1 (RRM1) and excision repair cross-complementing gene-1 (ERCC1) are related to DNA synthesis and repair and essential in this regard. However, apart from the therapeutic benefit, their prognostic implication is controversial. Methods: In this retrospective study, paraffin-embedded tissue from 51 cases of pancreatic cancer and 29 cases of cholangiocarcinoma were evaluated for RRM1 and ERCC1 expression by immunohistochemical technique along with 18 control pancreatic and biliary tissues. The semiquantitatively H score was calculated based on stain distribution and stain intensities. Results: Both RRM1 and ERCC1 expression were high in tumor epithelium than in controls (RRM1: the difference was statistically significant in cholangiocarcinoma (P = 0.008); ERCC1: the difference was statistically significant both in pancreatic and cholangiocarcinoma (P < 0.05)]. However, no correlation was noted between RRM1 and ERCC1-low and high tumors with histological markers of prognosis and overall survival in these patients. Conclusions: The present study adds further evidence against the controversy that if RRM1 and ERCC1 expression in pancreatic and biliary carcinomas have any prognostic significance apart from their proven therapeutic benefits in these tumors.Khushbu KhetanRanjit K SahooVandana BalodaShalimarSreenivas VishnubhatlaAnoop SarayaNihar Ranjan DashAtul SharmaSiddhartha DattaGuptaPrasenjit DasWolters Kluwer Medknow Publicationsarticlecholangiocarcinomaexcision repair cross-complementing gene-1pancreatic adenocarcinomaprognosisribonucleotide reductase catalytic subunit m1PathologyRB1-214MicrobiologyQR1-502ENIndian Journal of Pathology and Microbiology, Vol 64, Iss 5, Pp 160-165 (2021)
institution DOAJ
collection DOAJ
language EN
topic cholangiocarcinoma
excision repair cross-complementing gene-1
pancreatic adenocarcinoma
prognosis
ribonucleotide reductase catalytic subunit m1
Pathology
RB1-214
Microbiology
QR1-502
spellingShingle cholangiocarcinoma
excision repair cross-complementing gene-1
pancreatic adenocarcinoma
prognosis
ribonucleotide reductase catalytic subunit m1
Pathology
RB1-214
Microbiology
QR1-502
Khushbu Khetan
Ranjit K Sahoo
Vandana Baloda
Shalimar
Sreenivas Vishnubhatla
Anoop Saraya
Nihar Ranjan Dash
Atul Sharma
Siddhartha DattaGupta
Prasenjit Das
Expression patterns and prognostic significances of RRM1 and ERCC1 in pancreatic carcinoma and cholangiocarcinoma
description Background: Aggressive pancreatobiliary tumors often require oxaliplatin-based therapies, instead of standard gemcitabine-based therapy and biomarker studies at diagnosis to decide the appropriate therapeutic regimen. The ribonucleotide Reductase catalytic subunit M1 (RRM1) and excision repair cross-complementing gene-1 (ERCC1) are related to DNA synthesis and repair and essential in this regard. However, apart from the therapeutic benefit, their prognostic implication is controversial. Methods: In this retrospective study, paraffin-embedded tissue from 51 cases of pancreatic cancer and 29 cases of cholangiocarcinoma were evaluated for RRM1 and ERCC1 expression by immunohistochemical technique along with 18 control pancreatic and biliary tissues. The semiquantitatively H score was calculated based on stain distribution and stain intensities. Results: Both RRM1 and ERCC1 expression were high in tumor epithelium than in controls (RRM1: the difference was statistically significant in cholangiocarcinoma (P = 0.008); ERCC1: the difference was statistically significant both in pancreatic and cholangiocarcinoma (P < 0.05)]. However, no correlation was noted between RRM1 and ERCC1-low and high tumors with histological markers of prognosis and overall survival in these patients. Conclusions: The present study adds further evidence against the controversy that if RRM1 and ERCC1 expression in pancreatic and biliary carcinomas have any prognostic significance apart from their proven therapeutic benefits in these tumors.
format article
author Khushbu Khetan
Ranjit K Sahoo
Vandana Baloda
Shalimar
Sreenivas Vishnubhatla
Anoop Saraya
Nihar Ranjan Dash
Atul Sharma
Siddhartha DattaGupta
Prasenjit Das
author_facet Khushbu Khetan
Ranjit K Sahoo
Vandana Baloda
Shalimar
Sreenivas Vishnubhatla
Anoop Saraya
Nihar Ranjan Dash
Atul Sharma
Siddhartha DattaGupta
Prasenjit Das
author_sort Khushbu Khetan
title Expression patterns and prognostic significances of RRM1 and ERCC1 in pancreatic carcinoma and cholangiocarcinoma
title_short Expression patterns and prognostic significances of RRM1 and ERCC1 in pancreatic carcinoma and cholangiocarcinoma
title_full Expression patterns and prognostic significances of RRM1 and ERCC1 in pancreatic carcinoma and cholangiocarcinoma
title_fullStr Expression patterns and prognostic significances of RRM1 and ERCC1 in pancreatic carcinoma and cholangiocarcinoma
title_full_unstemmed Expression patterns and prognostic significances of RRM1 and ERCC1 in pancreatic carcinoma and cholangiocarcinoma
title_sort expression patterns and prognostic significances of rrm1 and ercc1 in pancreatic carcinoma and cholangiocarcinoma
publisher Wolters Kluwer Medknow Publications
publishDate 2021
url https://doaj.org/article/0308f19bce6a47979b52fb9fb0ccd539
work_keys_str_mv AT khushbukhetan expressionpatternsandprognosticsignificancesofrrm1andercc1inpancreaticcarcinomaandcholangiocarcinoma
AT ranjitksahoo expressionpatternsandprognosticsignificancesofrrm1andercc1inpancreaticcarcinomaandcholangiocarcinoma
AT vandanabaloda expressionpatternsandprognosticsignificancesofrrm1andercc1inpancreaticcarcinomaandcholangiocarcinoma
AT shalimar expressionpatternsandprognosticsignificancesofrrm1andercc1inpancreaticcarcinomaandcholangiocarcinoma
AT sreenivasvishnubhatla expressionpatternsandprognosticsignificancesofrrm1andercc1inpancreaticcarcinomaandcholangiocarcinoma
AT anoopsaraya expressionpatternsandprognosticsignificancesofrrm1andercc1inpancreaticcarcinomaandcholangiocarcinoma
AT niharranjandash expressionpatternsandprognosticsignificancesofrrm1andercc1inpancreaticcarcinomaandcholangiocarcinoma
AT atulsharma expressionpatternsandprognosticsignificancesofrrm1andercc1inpancreaticcarcinomaandcholangiocarcinoma
AT siddharthadattagupta expressionpatternsandprognosticsignificancesofrrm1andercc1inpancreaticcarcinomaandcholangiocarcinoma
AT prasenjitdas expressionpatternsandprognosticsignificancesofrrm1andercc1inpancreaticcarcinomaandcholangiocarcinoma
_version_ 1718380712844853248